Cytek Biosciences, Inc.
Provides full spectrum flow cytometry solutions for cancer and cell biology research.
CTKB | US
Overview
Corporate Details
- ISIN(s):
- US23285D1090
- LEI:
- Country:
- United States of America
- Address:
- 47215 LAKEVIEW BOULEVARD, 94538 FREMONT
- Website:
- https://cytekbio.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of measuring, testing, navigating and control equipment; watches and clocks
Description
Cytek Biosciences, Inc. is a cell analysis solutions company dedicated to advancing cancer and cell biology research. The company develops, manufactures, and supplies a comprehensive suite of flow cytometry instruments, reagents, and software centered on its proprietary Full Spectrum Profiling (FSP) technology. This innovative approach enables scientists to conduct high-resolution, high-content, and high-sensitivity cell analysis, gaining deeper biological insights from a single sample. Cytek's portfolio, including its Aurora and Northern Lights systems, provides complete workflow solutions that make complex cell profiling more accessible and efficient, thereby accelerating scientific discovery. The company's products are for research use only.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cytek Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cytek Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cytek Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||